4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-22-025160
Chief Strategy & Dev. Officer sold 212,714 shares at an average $22.54 ($4,794,574)
- Chief Strategy & Dev. Officer acquired 212,714 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Desai Veeral · Chief Strategy & Dev. Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-19 | Exercise or conversion : show line 1 in the form | +106,357 | $1.00 | $106,357 | 384,568 | D |
| 2022-04-19 | Sale : show line 2 in the form | −106,357 | $22.74 | $2,418,558 | 278,211 | D |
| 2022-04-20 | Exercise or conversion : show line 3 in the form | +106,357 | $1.00 | $106,357 | 384,568 | D |
| 2022-04-20 | Sale : show line 4 in the form | −106,357 | $22.34 | $2,376,015 | 278,211 | D |
| Open-market sales · 212,714 sh · avg $22.54 · $4,794,574 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-19 | Exercise or conversion : show line 5 in the form Options (Rights to Buy) | −106,357 | 775,351 | D |
| 2022-04-20 | Exercise or conversion : show line 6 in the form Options (Rights to Buy) | −106,357 | 668,994 | D |
Loading xslF345X03/doc4.xml…